European Patent Office

T 0187/93 (Vaccines/GENENTECH) vom 05.03.1997

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:1997:T018793.19970305
Datum der Entscheidung
5. März 1997
Aktenzeichen
T 0187/93
Antrag auf Überprüfung von
-
Anmeldenummer
84305909.8
IPC-Klasse
A61K 39/245
Verfahrenssprache
Englisch
Verteilung
An die Kammervorsitzenden und -mitglieder verteilt (B)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
Vaccines based on membrane bound proteins and process for making them
Name des Antragstellers
GENENTECH, INC.
Name des Einsprechenden
Chiron Corporation
Kammer
3.3.04
Leitsatz
-
Schlagwörter
Main, first and second auxiliary requests - sufficiency of disclosure and support by the description (no)
Third auxiliary request - added matter (yes)
Fourth auxiliary request - sufficiency of disclosure - support by the description (yes)
Novelty (yes)
Inventive step (yes) no reasonable expectation of success
Orientierungssatz
If a given technical effect (here: immunoprotection in vivo) is solely relied upon in order to demonstrate that a claimed subject-matter (here: a vaccine against a viral pathogen and its production method) involves an inventive step, claims of a broad scope are not allowable under Articles 83 and 84 EPC when, on the basis of the disclosure in the European patent application or the European patent and of the common general knowledge at the date of filing or at the priority date, said technical effect cannot be achieved by the skilled person without undue burden within the whole range of application claimed (cf. points 2 to 7 of the Reasons).

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the Opposition Division with the order to maintain the patent with the claims 1 to 9 according to the fourth auxiliary request and the description and drawings to be adapted thereto.